DEA Earnings

DEA reported its earnings on 2026-02-23, showcasing a revenue of 87.04M against an estimate of 87.73M, resulting in a -0.78% surprise. The EPS was 0.77, surpassing the expected 0.37 by 108.11%. The stock experienced a -2.65% price change on the earnings day and a -2.36% change over the next five days, reflecting market reactions to the results.

Following DEA's earnings announcement on 2026-02-23, the stock price moved by -2.65% on the day of the release. Over the subsequent five days, it saw a -2.36% change. Historically, DEA's stock price tends to shift by an average of 1.29% in the 10 days leading up to earnings and -2.36% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate DEA's annual revenue to reach 89.36M, while the EPS is projected at 0.09. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between DEA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, DEA's stock price typically moves by 1.29% in the 10 days before its earnings and -2.36% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.09 and revenue of 89.36M.

The earnings call reveals a stable financial performance with a 6% YoY growth in Core FFO and high occupancy rates. The Q&A indicates optimism about the $1.5 billion pipeline and government efficiency, despite some management ambiguity. The completion of the FDA Atlanta facility and strong acquisition terms in Virginia are positive signs. While economic uncertainties and strategic risks exist, the company's focus on efficiency and partnerships suggests a positive outlook. Given the market cap, a 2%-8% positive stock movement is expected.